drugset / Trial / NCT01153711
Relative Bioavailability of of Olodaterol and Ketoconazole
RandomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial is intended to investigate a possible effect of the p-gp inhibitor ketoconazole on the bioavailability of olodaterol
Timeline
- Start
- 2010-05
- Primary completion
- 2010-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketoconazole | Small molecule | 400 mg | Oral |
| Subject | Olodaterol | Small molecule | 10 ug | Inhaled |